These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Subclinical vasculitis in polymyalgia rheumatica. Marzo-Ortega H; McGonagle D; O'Connor P; Pease C; Emery P Ann Rheum Dis; 2001 Nov; 60(11):1058-9. PubMed ID: 11602479 [No Abstract] [Full Text] [Related]
6. Polymyalgia rheumatica and temporal arteritis: evidence and guidelines for diagnosis and management in older people. Frearson R; Cassidy T; Newton J Age Ageing; 2003 Jul; 32(4):370-4. PubMed ID: 12851178 [TBL] [Abstract][Full Text] [Related]
15. Methotrexate in polymyalgia rheumatica: kernel of truth or curse of Tantalus? Stone JH Ann Intern Med; 2004 Oct; 141(7):568-9. PubMed ID: 15466775 [No Abstract] [Full Text] [Related]
16. Polymyalgia rheumatica and its links with giant cell arteritis. Charlton R Clin Med (Lond); 2008 Oct; 8(5):498-501. PubMed ID: 18975481 [TBL] [Abstract][Full Text] [Related]
17. [Polymyalgia rheumatica and giant-cell temporal arteritis]. Tereshchenko IV Klin Med (Mosk); 2006; 84(8):25-30. PubMed ID: 17087187 [TBL] [Abstract][Full Text] [Related]
18. BSR and BHPR guidelines for the management of polymyalgia rheumatica. Dasgupta B; Borg FA; Hassan N; Barraclough K; Bourke B; Fulcher J; Hollywood J; Hutchings A; Kyle V; Nott J; Power M; Samanta A; Rheumatology (Oxford); 2010 Jan; 49(1):186-90. PubMed ID: 19910443 [No Abstract] [Full Text] [Related]